150 related articles for article (PubMed ID: 31452197)
1. Will Daratumumab be the next game changer in early thymic precursor-acute lymphoblastic leukaemia?
Mirgh S; Ahmed R; Agrawal N; Khushoo V; Garg A; Francis S; Tejwani N; Singh N; Bhurani D
Br J Haematol; 2019 Oct; 187(2):e33-e35. PubMed ID: 31452197
[No Abstract] [Full Text] [Related]
2. Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia.
Cerrano M; Castella B; Lia G; Olivi M; Faraci DG; Butera S; Martella F; Scaldaferri M; Cattel F; Boccadoro M; Massaia M; Ferrero D; Bruno B; Giaccone L
Br J Haematol; 2020 Oct; 191(1):e28-e32. PubMed ID: 32686081
[No Abstract] [Full Text] [Related]
3. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
[TBL] [Abstract][Full Text] [Related]
4. Daratumumab in T-cell acute lymphoblastic leukaemia: A case report and review of the literature.
Ruhayel SD; Valvi S
Pediatr Blood Cancer; 2021 May; 68(5):e28829. PubMed ID: 33245179
[No Abstract] [Full Text] [Related]
5. Daratumumab at the frontiers of post-transplant refractory T-acute lymphoblastic leukemia-a worthwhile strategy?
Bonda A; Punatar S; Gokarn A; Mohite A; Shanmugam K; Nayak L; Bopanna M; Cheriyalinkal Parambil B; Khattry N
Bone Marrow Transplant; 2018 Nov; 53(11):1487-1489. PubMed ID: 29884853
[No Abstract] [Full Text] [Related]
6. Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia.
Fulcher J; Berardi P; Christou G; Villeneuve PJA; Bredeson C; Sabloff M
Leuk Lymphoma; 2021 Sep; 62(9):2295-2297. PubMed ID: 33749497
[No Abstract] [Full Text] [Related]
7. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
[TBL] [Abstract][Full Text] [Related]
8. Very high frequencies of leukaemia-initiating cells in precursor T-acute lymphoblastic leukaemia may be obscured by cryopreservation.
Greystoke BF; Huang X; Wilks DP; Atkinson S; Somervaille TC
Br J Haematol; 2013 Nov; 163(4):538-41. PubMed ID: 23927465
[No Abstract] [Full Text] [Related]
9. Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia.
Vogiatzi F; Winterberg D; Lenk L; Buchmann S; Cario G; Schrappe M; Peipp M; Richter-Pechanska P; Kulozik AE; Lentes J; Bergmann AK; Valerius T; Frielitz FS; Kellner C; Schewe DM
Blood; 2019 Aug; 134(8):713-716. PubMed ID: 31311816
[No Abstract] [Full Text] [Related]
10. Terminal deoxynucleotidyl transferase (TdT) negative early T cell precursor acute lymphoblastic leukemia (ETP-ALL) with spontaneous acute kidney injury.
Kidoguchi K; Yokoo M; Umino A; Aoki S; Kimura S
Ann Hematol; 2020 Apr; 99(4):885-886. PubMed ID: 32025838
[No Abstract] [Full Text] [Related]
11. Pseudohyperkalemia due to severe leukocytosis: case presentation.
Claver-Belver N; Cano-Corres R; Miró-Cañís S; Berlanga-Escalera E
Clin Chem Lab Med; 2016 Dec; 54(12):e365-e367. PubMed ID: 27269895
[No Abstract] [Full Text] [Related]
12. Case Study Interpretation--Houston: Case 3. Early T-cell precursor-acute lymphoblastic leukemia.
Park S
Cytometry B Clin Cytom; 2011; 80(4):261-3. PubMed ID: 21638770
[No Abstract] [Full Text] [Related]
13. Low-dose nivolumab-induced responses in acute lymphoblastic leukaemia relapse after allogeneic haematopoietic stem cell transplantation.
Chan TSY; Sim JPY; Kwong YL
Ann Hematol; 2017 Sep; 96(9):1569-1572. PubMed ID: 28573313
[No Abstract] [Full Text] [Related]
14. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
Khogeer H; Rahman H; Jain N; Angelova EA; Yang H; Quesada A; Ok CY; Sui D; Wei P; Al Fattani A; Pierce S; Loghavi S; Lamb A; Hu P; Thakral B; Kanagal-Shamanna R; Jorgensen JL; Jabbour EJ; Kantarjian HM; Medeiros LJ; Khoury JD
Br J Haematol; 2019 Aug; 186(4):538-548. PubMed ID: 31115909
[TBL] [Abstract][Full Text] [Related]
15. CD33, not early precursor T-cell phenotype, is associated with adverse outcome in adult T-cell acute lymphoblastic leukaemia.
Guo RJ; Bahmanyar M; Minden MD; Chang H
Br J Haematol; 2016 Mar; 172(5):823-5. PubMed ID: 26123477
[No Abstract] [Full Text] [Related]
16. Monitoring of minimal residual disease in early T-cell precursor acute lymphoblastic leukaemia by next-generation sequencing.
Pan X; Nariai N; Fukuhara N; Saito S; Sato Y; Katsuoka F; Kojima K; Kuroki Y; Danjoh I; Saito R; Hasegawa S; Okitsu Y; Kondo A; Onishi Y; Nagami F; Kiyomoto H; Hozawa A; Fuse N; Nagasaki M; Shimizu R; Yasuda J; Harigae H; Yamamoto M
Br J Haematol; 2017 Jan; 176(2):318-321. PubMed ID: 26822323
[No Abstract] [Full Text] [Related]
17. Type B lactic acidosis due to Warburg effect in a child presenting with T cell acute lymphoblastic leukaemia: a milder phenotype.
Khera S; Pramanik SK; Kalra S; Dwivedi A
BMJ Case Rep; 2020 Mar; 13(3):. PubMed ID: 32188616
[TBL] [Abstract][Full Text] [Related]
18. Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia.
Ganzel C; Kharit M; Duksin C; Rowe JM
Haematologica; 2018 Oct; 103(10):e489-e490. PubMed ID: 29954929
[No Abstract] [Full Text] [Related]
19. Pseudohyperkalaemia with acute leukaemia: association with pneumatic tube transport of blood specimens.
Ku AS; Chen RH; Law RL
Hong Kong Med J; 2014 Apr; 20(2):158-60. PubMed ID: 24714171
[TBL] [Abstract][Full Text] [Related]
20. Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma.
Luskin MR; Ganetsky A; Landsburg DJ; Loren AW; Porter DL; Nasta SD; Svoboda J; Luger SM; Frey NV
Br J Haematol; 2016 Jul; 174(2):332-4. PubMed ID: 26403537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
